MedTrace Logo

Tempus Priority Study: A Pan-tumor Observational Study

NCT05179824 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-05-06

No results posted yet for this study

Summary

Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.

Conditions

Interventions

OTHER

Observation

No Intervention

Sponsors & Collaborators

Principal Investigators

  • Kristiyana Kaneva, MD, MS, MBA · Tempus AI, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2026-10-19
Completion
2030-10-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05179824 on ClinicalTrials.gov